400-1022-688
CH 中文版 ENGLISH
  • Home
  • About Us
    The CompanyCertificationISO 13485 and CE PartnersInvestor RelationsAwardsHistory
  • Technology
    Time-resolved fluorescence immunoassayLatex particle-enhanced turbidimetric immunoassay
  • Products
    PocRoc Anti-SARS-CoV-2 IgG/IgM Rapid Test SARS-CoV-2 IgGIgM Antibody Rapid Test Kit Germcon Instant Hand SanitizerPOCT testing kitsDry Chemistry AnalyzerProducts for biofilm investigationsNanoparticlesLab Consumable
  • Service
    Technical SupportDownload
  • News
    NewsCulture
  • Careers
    Job OpeningsPeople Philosophy
  • Contact Us
    Corporate AddressMarketing NetworkOnline Request

About Us

  • The Company
  • Certification
  • ISO 13485 and CE
  • Partners
  • Investor Relations
  • Awards
  • History
Investor Relations
Location:Home >About Us >Investor Relations
Earlier
Mar. 2014

CFDA approvals for five immunoassay reagents adaptable to most chemical analyzers were obtained

Feb. 2014

CFDA approvals for time-resolved fluorescence immunochromatographic analyzer were obtained

Sep. 2013

Lumigenex passed The first Food and Drug Administration by the Suzhou Municipal Quality Management System Assessment

HIGHLIGHT © 2015 www.lumigenex.com All Rights Reserved. 苏ICP备10204914号-1 技术支持:空谷网络技术支持: